GlassScriptPhysician profile
Karen Lyda
NPI 1366532947
$7,142.16
in general payments reported to CMS, 2019-2025
13 companies · $849 in 2025
The $849 reported for 2025 was more than what 77% of Psychiatric/Mental Health (Nurse Practitioner) providers received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $205 · 2022: $925 · 2023: $566 · 2024: $4,597 · 2025: $849.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,697 · Honoraria: $1,925 · Travel and Lodging: $1,389.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,697.47 |
| Honoraria | $1,925.00 |
| Travel and Lodging | $1,389.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $3,743.01 | 2024-2025 | Qelbree |
| Tris Pharma INC | $1,023.66 | 2022-2025 | Dyanavel Xr, Onyda Xr |
| Alkermes, INC. | $771.63 | 2021-2025 | Lybalvi, Aristada |
| Otsuka America Pharmaceutical, INC. | $367.09 | 2021-2024 | Rexulti, Abilify Maintena |
| Sunovion Pharmaceuticals INC. | $361.09 | 2021-2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $220.17 | 2022-2025 | Caplyta |
| Abbvie INC. | $168.45 | 2023-2024 | |
| Bioxcel Therapeutics, INC. | $160.84 | 2023 | Igalmi |
| E.R. Squibb & Sons, L.L.C. | $158.38 | 2024 | |
| Merck Sharp & Dohme LLC | $65.07 | 2024-2025 | Pifeltro, Delstrigo, Capvaxive |
| Collegium Pharmaceutical, INC. | $62.58 | 2025 | Jornay Pm |
| Gilead Sciences, INC. | $23.76 | 2025 | |
| Viiv Healthcare Company | $16.43 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karen Lyda listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.